Explore detailed information on the case number App_32868/2025 involving Amgen, Amgen Biofarmaceutica LDA, Amgen AB, and others and Alexion Pharmaceuticals which was filed on 14 Jul, 2025.

Case Details

    Case Number:

    App_32868/2025

    Filing Date:

    14 Jul, 2025

    Proceeding Type:

    Application

    Action/Application:

    Application Rop262A

    Plaintiffs:

    • Amgen Gmbh
    • Amgen Biofarmaceutica Lda
    • Amgen Ab
    • Amgen S.A.S
    • Amgen Technology (Ireland) Unlimited Company
    • Amgen N.V
    • Amgen Zdravila D.O.O
    • Amgen S.R.L

    Defendants:

    • Alexion Pharmaceuticals, Inc

Case Decision

Decision pending - set alert to receive updates

More cases on Amgen

This table lists the related cases associated with the patent, including case numbers, plaintiffs, and defendants involved in each case.

Last updated on: Aug 21, 2025
Case NumberFiling DatePlaintiffsDefendants
ORD_34329/2025Aug 5, 2025AmgenRegeneron Pharmaceuticals
ORD_34329/2025Aug 5, 2025AmgenRegeneron Pharmaceuticals
ORD_34328/2025Aug 5, 2025AmgenSanofi Winthrop Industrie, Sanofi Aventis Groupe, Sanofi Aventis Deutschland

More cases on Alexion Pharmaceuticals

This table lists the related cases associated with the patent, including case numbers, plaintiffs, and defendants involved in each case.

Last updated on: Aug 21, 2025
Case NumberFiling DatePlaintiffsDefendants
ACT_33390/2025Jul 22, 2025Samsung Bioepis NLAlexion Pharmaceuticals
ACT_33390/2025Jul 22, 2025Samsung Bioepis NLAlexion Pharmaceuticals
App_33372/2025Jul 21, 2025Amgen Zdravila DOO, Amgen, Amgen AB, Amgen Technology Ireland Unlimited, Amgen, Amgen Biofarmaceutica LDA, Amgen, AmgenAlexion Pharmaceuticals